13. HRVATSKI
ONKOLOŠKI
KONGRES

03.-06.09.2020. VIRTUALNI KONGRES

Sadržaj stranice

Objava izabranih postera

Galerija postera - pregled

Postere je putem filtera moguće pregledavati po nazivu i autoru, a LINK Vas vodi na poster koji možete komentirati

NaslovAutorPrezentacije
Multinational Survey of Burnout Syndrome in Eastern European OncologistsDavor KustLink
Response to neoadjuvant chemoradiotherapy for rectal adenocarcinoma: A single center experienceMarin ŠunjićLink
Impact of first-line tyrosine kinase inhibitors dose reduction on clinical outcomes in patients with metastatic kidney cancer: a single institution experienceMarija MiletićLink
Mucositis during the treatment of head and neck cancer patients with radiotherapy +/- chemotherapy – real clinical practice experienceGordana Berić JozićLink
NIVOLUMAB IMMUNOTHERAPY AS A PART OF THE EXPANDED ACCESS PROGRAMS FOR THE TREATMENT OF PATIENTS WITH LUNG CARCINOMAKresimir TomićLink
LOCAL CONTROL OF LOCALLY ADVANCED CERVICAL CANCER IN PATIENTS TREATED WITH PRIMARY CONCOMITANT CHEMOBRACHYRADIOTHERAPY IN DEPARTMENT OF ONCOLOGY, UNIVERSITY HOSPITAL MOSTARKresimir TomićLink
A RARE HER-2 POSITIVE NEUROENDOCRINE CARCINOMA OF THE BREAST: A 9-YEAR FOLLOW-UP CASE REPORTMarija KraljevićLink
Analysis of the application of different clinical CT imaging protocols as factors in the calculation of absorbed dose distributions using the Elekta Monaco radiotherapy planning systemManda Švabić KolacioLink
CASE PRESENTATION: ALK-POSITIVE METASTATIC LUNG CANCERKresimir TomićLink
Comparison of two planning techniques (F-IMRT/I-IMRT) for post-operative radiotherapy treatment of prostate cancer Nevena ObajdinLink
Treatment outcomes by primary tumor location in patients with metastatic colorectal cancer at the Department of Oncology and Radiotherapy, University Hospital of Split during 2017 - a retrospective analysis.Andrija KatićLink
Can optimally organized cancer care have an impact on the transition of patients with metastatic colorectal cancer through treatment lines? - a retrospective observational study at the Department of Oncology and Radiotherapy, University Hospital of Split.Andrija KatićLink
The impact of liver resection on tretment outcomes of metastatic colorectal cancer patients at the Department of Oncology and Radiotherapy, University Hospital of Split during 2017 - a retrospective analysis.Andrija KatićLink
Molecular profiling frequency of metastatic colorectal carcinoma and it`s impact on the outcomes: a single institution status report in 2017Dora ČerinaLink
EXPERIENCES WITH NEOADJUVANT THERAPY FOR BREAST CANCER IN OUR CLINIC IN 2018Marija PancirovLink
FIRST EXPERIENCES OF ALPELISIB TREATMENT OF HR + HER2- METASTATIC BREAST CARCINOMA IN CROATIAMarija PancirovLink
Immune checkpoint inhibitors combined with chemotherapy in extensive-stage small-cell lung cancer – single center experienceMarko JakopovićLink
HEMATOLOGIC TOXICITY OF CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITORS PALBOCICLIB AND RIBOCICLIB DURING FIRST THREE CYCLES OF 1ST LINE TREATMENT OF METASTATIC BREAST CANCER - RETROSPECTIVE ANALYSIS IN SINGLE CENTREAna MajićLink
The role of genetic testing in breast cancer patients undergoing neoadjuvant treatmentViktor ŠabarićLink
Non-BRCA Germline Pathogenic Variants in Breast Cancer Patients Tested at the University Hospital Center ZagrebNikolina LonjakLink
Genetic Assessment and Treatment Decision-Making in Patients with Metastatic Breast Cancer in University Hospital Center ZagrebKristina KanceljakLink
Making of a clinically useful questionnaire for assessment of emotional distress in patients with cancerPetra RadićLink
Pretreatment Ki67 and the efficacy of neoadjuvant chemotherapy in breast cancerMelita Perić BaljaLink
How to distinguish primary from acquired achalasia?: a patient with achalasia and cancer of both kidneysRosana Troskot PerićLink
Tolerability of bevacizumab in elderly patients with ovarian cancer: an experience from the Department of Gynecologic Oncology in the University Hospital Centre ZagrebKristina KatićLink
V50 – predictive marker in radiotherapy induced hypothyroidism in head and neck cancer patientsNeva Purgar LevardaLink
TREATMENT WITH CDK 4/6 INHIBITORS IN METASTATIC HORMON RECEPTOR POSITIVE, HER-2 NEGATIVE BREAST CANCER – A SINGLE CENTER EXPERIENCEKristina UrchLink
MULTIDISCIPLINARY TEAM FOR THORACIC TUMORS AT UNIVERSITY HOSPITAL CENTER SESTRE MILOSRDNICE IN 2019Neva Purgar LevardaLink
FIRST EXPERIENCES OF ALPELISIB TREATMENT OF HR + HER2- METASTATIC BREAST CARCINOMA IN CROATIAMarija PancirovLink
Prostate cancer treatment decision support tool for patients: development and translation of smart phone APP to the clinic. Results of the prospective pilot studyJure MurgićLink
NEOADJUVANT THERAPY IN BREAST CANCER – A SINGLE CENTER EXPERIENCEDora FranceschiLink
ANGIOMYXOMA TESTIS: A rare caseVladimir FerenčakLink
Multidisciplinary surgical approach to the treatment of renal cell cancer stage T3cVladimir FerenčakLink
Could ratio of untreated/treated patients with metastatic colorectal carcinoma indicate it`s quality of care?Dora ČerinaLink
Molecular profiling frequency of metastatic colorectal carcinoma and it`s impact on the outcomes: a single institution status report in 2017Dora ČerinaLink
Immunotherapy in treatment of metastatic melanoma at University Hospital Center Sestre MilosrdniceKristina UrchLink
Regulation of PD-1/PD-L1 pathway in malignant melanoma – a pilot studyDamir VučinićLink
Melena caused by gastric lipomaTomislav PavlovićLink
Early experience with neoadjuvant chemotherapy in musle-invasive bladder cancer: results from single institution retrospective evaluationAngela PrgometLink
Institutional data on survival and disease control for early and locally advanced breast cancer patients in the era conservative surgical and adjuvant oncological approaches Ana Car PeterkoLink
Assessment of creatinine level rise in cancer patients treated with ribociclib and antihormonal therapy at the University Hospital for TumorsPetra LepetićLink